[Treatment modalities of hydatid cysts of the liver: progress or revolution?].
Debonne
J M
JM
Service d'Hépato-Gastro-Entérologie, Hôpital d'Instruction des Armées Laveran, Marseille-Armées, France.
Legall
P
P
Rey
P
P
Coton
T
T
Carre
D
D
Guisset
M
M
Klotz
F
F
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015766:Albendazole / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D000871:Anthelmintics / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D000969:Antinematodal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D002648:Child; D004351:Drug Resistance; D004444:Echinococcosis, Hepatic / Q000188:drug therapy*; D000431:Ethanol / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D005544:Forecasting; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D008463:Mebendazole / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D008875:Middle Aged; D019152:Paracentesis / Q000379:methods; D011159:Population Surveillance; D012008:Recurrence; D013997:Time Factors; D018084:Ultrasonography, Interventional
D000871:Anthelmintics; D000969:Antinematodal Agents; D000431:Ethanol; D008463:Mebendazole; D015766:Albendazole
Modalites therapeutiques du kyste hydatique du foie: avancée ou révolution?